RAdiotherapy With FDG-PET Guided Dose-PAINTing Compared With Standard Radiotherapy for Primary Head and Neck Cancer-3 (RADPAINT-3)
RAdiotherapy With FDG-PET Guided Dose-PAINTing Compared With Standard Radiotherapy for Primary Head and Neck Cancer-3 Randomized, Multicentre, Phase II Trial
Sponsor: Oslo University Hospital
Listed as NCT06297902, this NA trial focuses on Head and Neck Cancer and Radiotherapy Side Effect and remains actively recruiting participants. Sponsored by Oslo University Hospital, it has been updated 7 times since 2024, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
7 versions recorded-
Feb 2026 — Present [monthly]
Recruiting NA
-
Aug 2025 — Feb 2026 [monthly]
Recruiting NA
-
Mar 2025 — Aug 2025 [monthly]
Recruiting NA
-
Jan 2025 — Mar 2025 [monthly]
Recruiting NA
-
Sep 2024 — Jan 2025 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting · Phase: PHASE2 → NA
▶ Show 2 earlier versions
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting PHASE2
-
Apr 2024 — Jul 2024 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Oslo University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .